Edmund Schweppe (![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
edschweppe) wrote2021-05-10 05:32 pm
edschweppe) wrote2021-05-10 05:32 pm
Entry tags:
Local (and not-so-local) COVID-19 updates
As of 5PM today, the Commonwealth of Massachusetts is reporting 14 newly reported confirmed deaths (8 more than yesterday - up 133.3%) for a total of 17,344 deaths, 446 newly reported confirmed cases (209 less than yesterday - down 31.9%) for a total of 653,636 cases, and 23,693 newly reported molecular tests (32,054 less than yesterday - down 57.5%). The seven day average positivity rate is 1.26%, compared to 1.24% yesterday. Excluding higher education, the seven day average positivity rate is 2.11%, compared to 2.11% yesterday. The number of estimated active cases was 18,441 (305 less than yesterday - down 1.6%). The state also reported 2 newly reported probable deaths (2 more than yesterday) for a total of 354 and 28 newly reported probable cases (175 less than yesterday - down 86.2%) for a total of 44,236. Combining the confirmed and probable numbers gives 16 new deaths for a total of 17,698 and 474 new cases for a total of 697,872. There were 427 COVID-19 patients in hospital (11 less than yesterday - down 2.5%), 117 COVID-19 patients in ICUs (7 less than yesterday - down 5.6%) and 77 COVID-19 patients on ventilators (intubated) (3 more than yesterday - up 4.1%).
Of the four overview trends (formerly the Page 2 "key metrics"), the 7-day average of newly confirmed cases is 625.0 (2 less than yesterday - down 0.3%), 298% above the lowest observed value of 157.0 on 7/4/2020 and 90.0% below the highest observed value of 6,239.0 on 1/8/2021. The 7-day weighted average of positive molecular test rate is 1.26% (0 more than yesterday - up 1.0%), 63% above the lowest observed value of 0.8% on 9/21/2020 and 95% below the highest observed value of 27.7% on 4/15/2020. The 7-day average number of COVID-19 patients in hospital is 470.0 (12 less than yesterday - down 2.5%), 203% above the lowest observed value of 155.0 on 8/26/2020 and 88% below the highest observed value of 3,874.0 on 4/27/2020. The 7-day average number of COVID-19 deaths is 7.0 (1 more than yesterday - up 16.7%), 0% above the lowest observed value of 7.0 on 5/8/2021 and 96% below the highest observed value of 175.0 on 4/24/2020.
Statewide, hospitals reported 9,042 non-ICU beds, of which 6,958 (77.0%) were occupied by non-COVID patients, 310 (3.4%) were occupied by COVID patients, and 1,774 (19.6%) remained available. Hospitals also reported 1,379 ICU beds, of which 868 (62.9%) were occupied by non-COVID patients, 117 (8.5%) were occupied by COVID patients, and 394 (28.6%) remained available. By comparison, hospitals reported yesterday a total of 9,184 non-ICU beds, of which 7,240 (78.8%) were occupied by non-COVID patients, 314 (3%) were occupied by COVID patients, and 1,630 (17.7%) remained available. Hospitals also reported yesterday a total of 1,381 ICU beds, of which 895 (64.8%) were occupied by non-COVID patients, 124 (9.0%) were occupied by COVID patients, and 362 (26.2%) remained available.
Two weeks ago, the 7 day confirmed case average was 1,021.0, the 7 day confirmed deaths average was 9.0, the 7 day hospitalization average was 661.0, and the 7 day weighted average positivity rate was 1.72% (or 3.00% excluding higher education).
The daily raw data file used to create this report is available here.
Deaths are up day-to-day; cases are down but tests are down proportionately more, implying that weekend reporting delays may be impacting the case counts; neither of those is particularly great news. The estimated active case count is down, though, as are the hospitalization counts. Seven-day averages for cases and hospitalizations are down compared to yesterday, while those for percent-positive and deaths are up. All in all, a mixed bag.
Good news on the vaccine front, though, as the Pfizer/BioNTech vaccine has just had its emergency use authorization expanded to include 12 to 15 year olds:
The town of Acton's current Google Data Studio dashboard is showing 12 active and 970 cumulative cases as of May 9. The most recent "newsflash style update" at 6PM on April 27, 2021 reported 951 cumulative cases with 13 individuals in isolation, 906 persons recovered and 32 fatalities.
Of the four overview trends (formerly the Page 2 "key metrics"), the 7-day average of newly confirmed cases is 625.0 (2 less than yesterday - down 0.3%), 298% above the lowest observed value of 157.0 on 7/4/2020 and 90.0% below the highest observed value of 6,239.0 on 1/8/2021. The 7-day weighted average of positive molecular test rate is 1.26% (0 more than yesterday - up 1.0%), 63% above the lowest observed value of 0.8% on 9/21/2020 and 95% below the highest observed value of 27.7% on 4/15/2020. The 7-day average number of COVID-19 patients in hospital is 470.0 (12 less than yesterday - down 2.5%), 203% above the lowest observed value of 155.0 on 8/26/2020 and 88% below the highest observed value of 3,874.0 on 4/27/2020. The 7-day average number of COVID-19 deaths is 7.0 (1 more than yesterday - up 16.7%), 0% above the lowest observed value of 7.0 on 5/8/2021 and 96% below the highest observed value of 175.0 on 4/24/2020.
Statewide, hospitals reported 9,042 non-ICU beds, of which 6,958 (77.0%) were occupied by non-COVID patients, 310 (3.4%) were occupied by COVID patients, and 1,774 (19.6%) remained available. Hospitals also reported 1,379 ICU beds, of which 868 (62.9%) were occupied by non-COVID patients, 117 (8.5%) were occupied by COVID patients, and 394 (28.6%) remained available. By comparison, hospitals reported yesterday a total of 9,184 non-ICU beds, of which 7,240 (78.8%) were occupied by non-COVID patients, 314 (3%) were occupied by COVID patients, and 1,630 (17.7%) remained available. Hospitals also reported yesterday a total of 1,381 ICU beds, of which 895 (64.8%) were occupied by non-COVID patients, 124 (9.0%) were occupied by COVID patients, and 362 (26.2%) remained available.
Two weeks ago, the 7 day confirmed case average was 1,021.0, the 7 day confirmed deaths average was 9.0, the 7 day hospitalization average was 661.0, and the 7 day weighted average positivity rate was 1.72% (or 3.00% excluding higher education).
The daily raw data file used to create this report is available here.
Deaths are up day-to-day; cases are down but tests are down proportionately more, implying that weekend reporting delays may be impacting the case counts; neither of those is particularly great news. The estimated active case count is down, though, as are the hospitalization counts. Seven-day averages for cases and hospitalizations are down compared to yesterday, while those for percent-positive and deaths are up. All in all, a mixed bag.
Good news on the vaccine front, though, as the Pfizer/BioNTech vaccine has just had its emergency use authorization expanded to include 12 to 15 year olds:
The Food and Drug Administration has agreed to let adolescents between the ages of 12 and 15 be vaccinated with the Pfizer and BioNTech Covid-19 vaccine, making it the first vaccine to be available for use in children under the age of 16.
The FDA announced Monday that it was altering the emergency use authorization for the vaccine. Its decision was based on a Phase 3 trial that showed the vaccine to be both safe and effective in the age group.
The companies announced Friday they had applied to the European Medicines Agency for a similar expansion of eligibility there.
The move positions the Pfizer and BioNTech vaccine to make early inroads into the adolescent market, as parents look to have their children immunized against Covid-19 in advance of next fall’s return to school. The company is already testing the vaccine in children aged 2 to 11 and plans to test it in children aged 6 months to 2 years in coming weeks.
Moderna is testing its vaccine in children, with one trial focused on adolescents aged 12 to 18 and a second looking at the safety and effectiveness of the vaccine in children 6 months to 12 years. Johnson and Johnson announced in early April that it has begun testing its one-dose vaccine in adolescents 12 to 17 years of age.
[ ... ]
The trial enrolled 2,260 children. There were 18 cases of Covid-19 infection in children in the placebo arm of the trial but none of the children who received vaccine became infected, resulting in a 100% efficacy estimate. Antibody levels in blood drawn from a subset of the children showed a robust response — stronger than the response seen in earlier trials of the vaccine involving people aged 16 to 25.
The town of Acton's current Google Data Studio dashboard is showing 12 active and 970 cumulative cases as of May 9. The most recent "newsflash style update" at 6PM on April 27, 2021 reported 951 cumulative cases with 13 individuals in isolation, 906 persons recovered and 32 fatalities.